Actively Recruiting

Phase 4
Age: 18Years - 120Years
All Genders
NCT06364540

Nebulized Ketamine to Nebulized Fentanyl for Treating Acute Painful Conditions in the ED

Led by Antonios Likourezos · Updated on 2025-06-04

150

Participants Needed

1

Research Sites

139 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

In situations where intravenous access is not readily available or is unobtainable and the intranasal route is not feasible, another non-invasive route of ketamine administration, such as inhalation via breath-actuated Nebulizer (BAN), is becoming a viable alternative. The BAN allows the controlled, patient-initiated delivery of analgesics in a measured and titratable fashion. (18) Ketamine has been studied as a nebulized drug in a lot of different settings and for a lot of different reasons, such as to treat acute pain after surgery (like a sore throat after being intubated), as a pre-medication for general anesthesia, to treat cancer pain, and as a therapy for asthmaticus. Our research team has published two case series of 10 adult patients who were given nebulized ketamine (via BAN) for a variety of acute traumatic and non-traumatic painful conditions. The patients showed a 60% decrease in pain and a small number of side effects. Furthermore, our group published a randomized, double-blind trial of 120 adult patients evaluating the analgesic efficacy and safety of nebulized ketamine at three different dosing regimens for acute pain in the ED (0.75 mg/kg, 1 mg/kg, and 1.5 mg/kg), showing similar analgesic efficacy between the three different dosing regimens for short-term (up to 120 minutes) pain relief. Lastly, we recently completed a randomized, double-blind, double-dummy clinical trial comparing the analgesic efficacy and safety of nebulized ketamine and intravenous ketamine in managing acute pain in adult ED patients, with data currently being analyzed. Nebulized fentanyl given in the ED to adults with acute traumatic and non-traumatic pain syndromes at a dose range of 1.5-4 mcg/kg showed the same or even better pain-relieving effects than IV fentanyl and IV morphine alone. Our objective is to compare the analgesic efficacy and rates of side effects of a 0.75 mg/kg dose of ketamine administered via breath-actuated nebulizer (BAN) to a dose of 3 mcg/kg of fentanyl administered via breath-actuated nebulizer (BAN) in adult patients presenting to the ED with acute painful conditions.

CONDITIONS

Official Title

Nebulized Ketamine to Nebulized Fentanyl for Treating Acute Painful Conditions in the ED

Who Can Participate

Age: 18Years - 120Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Acute painful condition
  • Pain score of 5 or more on an 11-point numeric rating scale
  • Patient is awake, alert, and oriented to person, place, and time
  • Patient understands the informed consent process and content
  • Patient can describe any side effects experienced
  • Patient can express their pain severity using the numeric rating scale
Not Eligible

You will not qualify if you...

  • Painful condition requiring urgent or emergency intervention in the ED
  • Altered mental status
  • Allergy to ketamine or fentanyl
  • Pregnant or breastfeeding
  • Weight over 100 kg
  • Presenting with head injury
  • Unstable vital signs (systolic blood pressure <90 or >180 mmHg, pulse rate <50 or >150 beats/min, respiration rate <10 or >30 breaths/min)
  • Unable to provide consent
  • History of alcohol or drug abuse
  • Use of opioids or opioid antagonist/agonist within 4-6 hours before arrival
  • Use of NSAIDs within 6 hours before arrival

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Maimonides Medical Center

Brooklyn, New York, United States, 11219

Actively Recruiting

Loading map...

Research Team

A

Antonios Likourezos, MA, MPH

CONTACT

S

Sergey Motov, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here